ArticleLeukemiaPublished
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, Temple University, University of Pennsylvania. Affiliation source
Publication record
- Type
- Article
- Venue
- Leukemia
- Published
- Topic
- Disease research
- Subject terms
- Cell Line, Tumor; Animals; Humans; Mice; Histone-Lysine N-Methyltransferase; Extracellular Signal-Regulated MAP Kinases; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays; Apoptosis; Cell Proliferation; Myeloid-Lymphoid Leukemia Protein
- PubMed ID
- 40148558
- PubMed Central ID
- PMC12055583
- Open access
- Yes, open
- Added to directory
- Source checked